Endo International (NASDAQ:ENDP) Issues Q1 2022 Earnings Guidance

Endo International (NASDAQ:ENDP – Get Rating) (TSE:ENL) updated its first quarter 2022 earnings guidance on Monday. The company provided earnings per share guidance of $0.350-$0.450 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.480. The company issued revenue guidance of $595 million-$635 million, compared to the consensus revenue estimate […]

Related Keywords

California ,United States ,Piper Sandler ,Endo International Plc ,Branded Pharmaceuticals ,Thomson Reuters ,Geode Capital Management ,Zacks Investment Research ,Generic Pharmaceuticals ,Parametric Portfolio Associates ,Marshall Wace ,International Pharmaceuticals ,York Mellon Corp ,Endo International ,Endo International Get Rating ,Barclays ,Get Rating ,State Teachers Retirement System ,Portfolio Associates ,Capital Management ,New York Mellon Corp ,International Plc ,Sterile Injectables ,Nasdaq Endp ,Endp ,Medical ,29264f20 ,Guidance ,Earnings ,Preannouncement ,